{"version":"1.0","provider_name":"Leitat Technological Center","provider_url":"https:\/\/leitat.org\/en\/","author_name":"Dissemination Manager","author_url":"https:\/\/leitat.org\/en\/blog\/author\/editor-wp\/","title":"Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas - Leitat Technological Center","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"j9IUZ5K9U5\"><a href=\"https:\/\/leitat.org\/en\/blog\/proyecto-modern\/\">Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/leitat.org\/en\/blog\/proyecto-modern\/embed\/#?secret=j9IUZ5K9U5\" width=\"600\" height=\"338\" title=\"&#8220;Proyecto MODERN: Avanzando en el Descubrimiento de Inhibidores Epigen\u00e9ticos para Tratar Alteraciones Neurol\u00f3gicas&#8221; &#8212; Leitat Technological Center\" data-secret=\"j9IUZ5K9U5\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/leitat.org\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/leitat.org\/wp-content\/uploads\/2024\/07\/modernnew.jpg","thumbnail_width":1920,"thumbnail_height":1080,"description":"Las enfermedades neurol\u00f3gicas, en su mayor\u00eda, tienen su origen en alteraciones en la expresi\u00f3n g\u00e9nica, regulada por mecanismos epigen\u00e9ticos dentro de las c\u00e9lulas neuronales. Sin embargo, este campo sigue siendo uno de los menos explorados en t\u00e9rminos terap\u00e9uticos, con una falta de f\u00e1rmacos espec\u00edficos disponibles actualmente. En el proyecto MODERN, la farmac\u00e9utica Oryzon, la Universidad [&hellip;]"}